Bosh sahifaORMP • NASDAQ
add
Oramed Pharmaceuticals, Inc.
Yopilish kursi
2,31 $
Kunlik diapazon
2,30 $ - 2,39 $
Yillik diapazon
2,00 $ - 3,67 $
Bozor kapitalizatsiyasi
94,33 mln USD
Oʻrtacha hajm
99,55 ming
Narx/foyda
23,43
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 3,09 mln | 6,77% |
Sof foyda | -19,62 mln | -508,91% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,48 | -500,00% |
EBITDA | -3,04 mln | -6,97% |
Amaldagi soliq stavkasi | -6,12% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 142,30 mln | -18,70% |
Jami aktivlari | 165,08 mln | -28,50% |
Jami passivlari | 9,56 mln | -88,44% |
Umumiy kapital | 155,52 mln | — |
Tarqatilgan aksiyalar | 40,31 mln | — |
Narxi/balansdagi bahosi | 0,59 | — |
Aktivlardan daromad | -4,42% | — |
Kapitaldan daromad | -4,64% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -19,62 mln | -508,91% |
Operatsiyalardan naqd pul | -7,10 mln | -923,20% |
Sarmoyadan naqd pul | -34,26 mln | 54,39% |
Moliyadan naqd pul | -1,29 mln | -101,73% |
Naqd pulning sof oʻzgarishi | -42,65 mln | -3 183,22% |
Boʻsh pul | -277,62 ming | 40,85% |
Haqida
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
CEO
Tashkil etilgan
2006
Sayt
Xodimlar soni
15
